Does Epstein-Barr virus and intracellular Toll-like receptors affect the course of Hashimoto’s disease? Findings from studies on newly diagnosed patients

These findings highlight the importance of considering both viral reactivation and TLR activity in the treatment of HT. Understanding the interplay between EBV and intracellular TLRs may lead to development of new therapeutic approaches to mitigate the impact of these factors on the disease progression. Further research is warranted to investigate the mechanisms underlying this interaction and its implications for treatment strategies.